Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.60
-0.40 (-0.68%)
Nov 20, 2025, 10:42 AM HKT

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21
Biopharmaceutical Research & Development and Commercialisation
464.18M
Log In
Log In
Log In
Biopharmaceutical Research & Development and Commercialisation Growth
18.63%
Log In
Log In
Log In

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21
Overseas
424.09M
Log In
Log In
Log In
Overseas Growth
8.67%
Log In
Log In
Log In
China
40.09M
Log In
Log In
Log In
China Growth
3917.60%
Log In
Log In
Log In